Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women diagnosed with triple-negative breast cancer (a specific type of breast cancer) who have not yet received any drug treatment for it
- Healthy women between the ages of 25 and 60 (confirm with trial site for the exact role of healthy participants in this trial)
Who may not be able to join:
- People who have diabetes
- People who have high blood pressure
- People with an active infection of any kind
- People who have HIV
- People who have Hepatitis B or Hepatitis C
- People with long-term inflammatory conditions
- People who currently have or have previously had any form of cancer
- People with heart disease
- People who are currently taking any medication
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alfredo Budillon, M.D., IRCCS I.N.T. "G. Pascale"
Phone: 08117770584
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Use of immunohistochemistry investigation (IHC); Prospective evaluation of expression of some selenoproteins by kit ELISA in plasma samples
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.